8K7 — UG Healthcare Share Price
Last trade - 00:00- SG$74.86m
- SG$88.46m
- SG$115.21m
- 44
- 59
- 73
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.46 | ||
| Price to Tang. Book | 0.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.65 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4.1% | ||
| Return on Equity | -3.52% | ||
| Operating Margin | -6.71% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 144.21 | 338.4 | 232.6 | 101.13 | 115.2 | 206.6 | n/a | 4.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +433.1 | +745.12 | -69.16 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
UG Healthcare Corporation Limited is a Malaysia-based investment holding company principally engaged in manufacturing and trading of gloves and other medical disposables products, such as latex examination gloves, nitrile examination gloves and other ancillary products under UNIGLOVES brand. Its segments include latex examination gloves, nitrile examination gloves and other ancillary products. Its disposable gloves offers both specialized products, with a variety of coatings, scents, colors, thickness, antimicrobial properties, and eco-friendly materials for more specialized users, as well as generic products. It owns and operates a downstream network of distribution companies with a local presence in Europe, United Kingdom, United States of America, China, Africa and South America, where it markets and sells its disposable gloves. It also distributes ancillary products including surgical, vinyl and cleanroom disposable gloves, reusable gloves, face masks and other medical disposables.
Directors
- Wah Pung Yip NEC (60)
- Keck Keong Lee CEO (62)
- Jun Yih Lee FID (37)
- Jun Linn Lee COO (35)
- Lee Jun Yih EDR (32)
- See Keong Wong EDR (53)
- Pek Wee Wong OTH (45)
- Mei Mei Low SEC
- Lip Chi Ng IND (50)
- Vincent Leow NID (43)
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- August 21st, 2014
- Public Since
- December 8th, 2014
- No. of Shareholders
- 3,612
- No. of Employees
- 628
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 623,825,811
- Address
- 21 Merchant Road, SEREMBAN, 70450
- Web
- https://www.ughealthcarecorporation.com/
- Phone
- +60 66772751
- Auditors
- Forvis Mazars LLP
Upcoming Events for 8K7
Similar to 8K7
AJJ Medtech Holdings
Singapore Exchange Securities Trading Ltd
Biolidics
Singapore Exchange Securities Trading Ltd
Medtecs International
Singapore Exchange Securities Trading Ltd
Pasture Holdings
Singapore Exchange Securities Trading Ltd
Riverstone Holdings
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 22:52 UTC, shares in UG Healthcare are trading at SG$0.12. This share price information is delayed by 15 minutes.
Shares in UG Healthcare last closed at SG$0.12 and the price had moved by +20% over the past 365 days. In terms of relative price strength the UG Healthcare share price has outperformed the FTSE Developed Asia Pacific Index by +12.88% over the past year.
The overall consensus recommendation for UG Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreUG Healthcare does not currently pay a dividend.
UG Healthcare does not currently pay a dividend.
UG Healthcare does not currently pay a dividend.
To buy shares in UG Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$0.12, shares in UG Healthcare had a market capitalisation of SG$74.86m.
Here are the trading details for UG Healthcare:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 8K7
Based on an overall assessment of its quality, value and momentum UG Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in UG Healthcare is SG$0.20. That is 66.67% above the last closing price of SG$0.12.
Analysts covering UG Healthcare currently have a consensus Earnings Per Share (EPS) forecast of SG$0.04 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like UG Healthcare. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -14.36%.
As of the last closing price of SG$0.12, shares in UG Healthcare were trading -1.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The UG Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
UG Healthcare's management team is headed by:
- Wah Pung Yip - NEC
- Keck Keong Lee - CEO
- Jun Yih Lee - FID
- Jun Linn Lee - COO
- Lee Jun Yih - EDR
- See Keong Wong - EDR
- Pek Wee Wong - OTH
- Mei Mei Low - SEC
- Lip Chi Ng - IND
- Vincent Leow - NID